Ariane Deep Knowledge AI Pharma Index
The Index Sponsor focuses on companies in the emerging industry of AI Pharma, as well as on large tech companies, which are linked to AI Pharma. According to the Index Sponsor, these companies are reducing production costs and time to market for new drugs and bring forward precision and personalised medicine into the mainstream. AI is moving the industry towards data-centric drug discovery, which according to the Index Sponsor will exponentially accelerate innovation in the sector in general. The Index Sponsor selects shares and may weight single constituents up to 20%. To ensure stability and to avoid excessive volatility of the Index despite significant single constituent weights in case the weight of selected share exceeds 10%, a market capitalization above USD 1b is needed.
Besides shares, the Index Sponsor may select derivative instruments on a discretionary basis for hedging purposes.